APA (7th ed.) Citation

R, S., L, C., S, D. L., G, I., F, L., P, S., . . . C, P. (2026). Multidisciplinary therapy managements in endometrial and renal cancer patients treated with pembrolizumab and lenvatinib: A virtuous circle between oncologists and organ specialists. Critical reviews in oncology/hematology, 222, 105272. https://doi.org/10.1016/j.critrevonc.2026.105272

Chicago Style (17th ed.) Citation

R, Sabbatini, Cosmai L, De Leo S, Ianiro G, Luppi F, Spallarossa P, Vacchi C, and Porta C. "Multidisciplinary Therapy Managements in Endometrial and Renal Cancer Patients Treated with Pembrolizumab and Lenvatinib: A Virtuous Circle Between Oncologists and Organ Specialists." Critical Reviews in Oncology/hematology 222 (2026): 105272. https://doi.org/10.1016/j.critrevonc.2026.105272.

MLA (9th ed.) Citation

R, Sabbatini, et al. "Multidisciplinary Therapy Managements in Endometrial and Renal Cancer Patients Treated with Pembrolizumab and Lenvatinib: A Virtuous Circle Between Oncologists and Organ Specialists." Critical Reviews in Oncology/hematology, vol. 222, 2026, p. 105272, https://doi.org/10.1016/j.critrevonc.2026.105272.